Study of Ambrisentan in Participants With Pulmonary Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 17, 2008

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Pulmonary Hypertension
Interventions
DRUG

Ambrisentan

Tablet administered orally once daily

Trial Locations (46)

1605

Clinica Independencia Munro, Buenos Aires

2010

St. Vincent's Hospital, Darlinghurst

3049

Department of Propedeutics of Internal Medicine No 1, Kiev

6000

Royal Perth Hospital, Perth

14080

Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City

14623

Mary Parkes Asthma Center University of Rochester, Rochester

15213

University of Pittsburgh Medical Center Presbyterian, Pittsburgh

29072

Lexington Pulmonary and Critical Care Medicine, Lexington

30030

Atlanta Institute for Medical Research, Inc., Atlanta

35294

University of Alabama at Birmingham, Birmingham

52242

University of Iowa, Iowa City

61039

Department of Acute Myocardial Infarction, Kharkiv

63110

Washington University Medical Center, St Louis

64718

Unidad de Investigacion Clinica en Medicina S.C., Monterrey

80045

University of Colorado Health Science Center, Aurora

85013

Arizona Pulmonary Specialists, Phoenix

109263

State Medico Stomatologic University, Moscow

121552

Russian Cardiology Research Complex, Moscow

194156

Almazov's Federal Heart, Blood & Endocrinology Center, Saint Petersburg

197022

Pavlov's State Medical University of St. Petersburg, Saint Petersburg

7500503

Centro de Estudios Cardiologicos Santiago Oriente, Santiago

7500691

Instituto Nacional del Torax, Santiago

8330074

Hospital Clinico de la Pontificia Universidad Catolica de Chile, Santiago

06030

University of Connecticut Health Center, Farmington

02111

Tufts Medical Center, Boston

02115

BACH Cardiology/Children's Hospital, Boston

Brigham & Women's Hospital, Boston

02118

Boston University Medical Center, Boston

07112

Newark Beth Israel Medical Center, Newark

02903

Rhode Island Hospital, Providence

B7600FZN

Instituto de Investigaciones Clínicas Mar del Plata, Buenos Aires

C1115AAb

Sanatorio Otamendi y Miroli, Buenos Aires

C1280AEB

Hospital Británico de Buenos Aires, Buenos Aires

C1437BZL

UAI Hospital Universitario, Buenos Aires

W3400AMZ

Instituto de Cardiologia J.F. Cabral, Corrientes

X5003DCE

Fundación Rusculleda, Córdoba

X5004FJE

Instituto de Cardiologia Hospital Italiano de Cordoba, Córdoba

X5016KEH

Hospital Privado Centro Medico de Cordoba S.A., Córdoba

S2001ODA

Hospital Italiano, Rosario

30380-090

Instituto de Pneumologia e Pediatria Clínica e Pesquisas LTDA ME, Belo Horizonte

90610 000

UBEA, Hospital Sao Lucas de Pontifícia, Porto Alegre

92020-090

Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre

21949-900

Hospital Universitario Clementino Fraga Filho, Rio de Janeiro

4023-062

Universidade do Estado de Sao Paulo - UNIFESP, São Paulo

CEP05403-000

Hospital das Clinicas da FMUSP, São Paulo

T1Y 6J4

Peter Lougheed Centre, Calgary

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00777920 - Study of Ambrisentan in Participants With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter